InvestorsHub Logo
Followers 38
Posts 5049
Boards Moderated 2
Alias Born 08/05/2002

Re: Liquidfan post# 706

Saturday, 06/04/2011 4:39:25 PM

Saturday, June 04, 2011 4:39:25 PM

Post# of 9201
Thanks Liquid.

Funny thing is my last note could go several paragraphs longer discussing the market opportunity for HEPI in nutraceuticals and foods based on cholesterol. I also only teased on inflammation. I'm not sure if people understand how large of a market there is for inflammation and how many illnesses have a root cause of inflammation in the body. How about HIV and other auto immune diseases???

Frankly I am not sure why HEPI hasn't emphasized these fractions in communications with shareholders. I don't know if pf3 or pf4 are actual discoveries. However multiple labs have looked at them and seem to think there is something novel. I understand these fractions are not single molecules. Maybe it is this complex combination that no one has seen before that causes the positive results. Dunno. There is also the method by which these fractions work. WSU says it is not the same as today's statins. No stress on the liver like statins. No side effects. Certainly seems like discovery potential there as well.

Anyway HEPI isn't getting any credit for where it is with Paz. IMO that will change.

Amigo Mike
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZIVO News